Por: The New York Times Health March 16, 2023
The drug company Novo Nordisk it would reduce the sticker prices of several of its insulin products by up to 70 percent, reversing years of price increases in the face of mounting pressure.The company did not announce any changes to the out-of-pocket costs for patients with diabetes, but said its existing programs kept those costs per vial for many patients. Instead, the price cut will affect only the list price, which is the starting point for... + full article
Forbes USA Business March 17, 2023
Topline Pharmaceutical giant Sanofi announced Thursday it will cut the price of its most commonly prescribed insulin by 78% and cap the monthly cost at $35, becoming the latest drug maker—behind Eli Lilly and Novo Nordisk—to slash insulin costs this month, amid growing calls... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
How the Other Insulin Makers Are Responding to Eli Lilly’s Price Cap | Time
Ars Technica USA Science March 15, 2023
Navigate Filter by topic Settings Front page layout Site theme - Mar 14, 2023 10:25 pm UTC / In this photo illustration, insulin pens manufactured by Novo Nordisk are displayed on March 14, 2023, in Miami, Florida. Share this story Heavyweight insulin maker Novo Nordisk said... + más
Eli Lilly caps out-of-pocket costs for insulin effective immediately | Fox Business
California latest to sue drug companies over insulin prices | ABC7
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
Fox Business USA Business March 14, 2023
Graviton Biopharmaceuticals Holdings CEO Sam Waksal argues there will be 'great growth' in the pharmaceutical industry. Pharmaceutical giant Novo Nordisk will lower the cost of several of its by up to 75% next year. Effective January 2024, the list price for insulin... + más
CNBC USA Health March 14, 2023
In this articleNovo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019.Alex Flynn Bloomberg Getty Images on Tuesday announced plans to slash the price of several insulin drugs by up to 75% in... + más
ABC7 USA Health January 13, 2023
People are losing their lives because they can't afford the drug, Bonta said.Daphne Dorsey, associate director for media relations for Eli Lilly, said the company is disappointed by the California Attorney General's false accusations. She said the average... + más
California Joins Other States in Suing Companies Over Insulin Prices | The New York Times
More than 1 million Americans ration their insulin as the drug's cost skyrockets | CBS News
CBS News USA Health October 18, 2022
About 1.3 million Americans rationed their prescribed doses of insulin last year to save money, a pattern one doctor said threatens the health — and even the lives — of people with diabetes. Many people are taking less than the recommended amount of insulin as the cost of... + más
3 in 10 uninsured Americans with diabetes may ration insulin: Study | ABC News
1.3 million Americans with diabetes rationed insulin in the past year, study finds | CNN
About iurex | Privacy Policy | Disclaimer |